EducationPhD University of Oslo (Norway), 1996 (Epidemiology)
MS University of Zagreb (Yugoslavia), 1991 (Biostatistics)
MD University of Zagreb (Yugoslavia), 1987 (Internal Medicine)
Contact Infoemail: firstname.lastname@example.org
4333 Brooklyn Ave NE, Rm 14-315
Seattle, WA 98195-9455
campus box: 359455
Dr. Kopjar is an internationally recognized scholar and expert in biostatistics and clinical epidemiology. He serves as an author/co-author on over 500 published original articles, reviews, technical reports and abstracts. His research interests include: spinal cord injury and diseases, neurosurgery, orthopaedics, preventive medicine and healthcare reform. Dr. Kopjar has been actively participating in the design, management and analysis of clinical trials and medical research for more than 30 years. He is a frequent contributor to such peer-reviewed publications as the Journal of Neurosurgery, the American Journal of Public Health, Spine and the Journal of Bone and Joint Surgery. In the 1990’s he served as the research director for the Norwegian Foundation for Health Services Research and department head of the Section for Preventive Medicine at the Norwegian National Institute of Public Health. As a consultant, he works closely with the leading global pharmaceutical, medical device and venture capital firms in regards to determining the efficacy, safety and investment value of medical technologies. Dr. Kopjar is active in a variety of research organizations including: AOSpine North America, The North American Spine Society (NASS), Cervical Spine Research Society (CSRS) and the International Scholarly Research Network (ISRN). He serves on the editorial board and as a reviewer for a number of academic journals and he is the current director of the Executive Master of Public Health program at the University of Washington. Dr. Kopjar holds the title of Distinguished Professor at Chongqing University in China. In the 2000's he held the title of Adviser to the Minister of Health for two European governments. He is a past recipient of the prestigious John M. Eisenberg Article-of-the-Year award.
Karpova A, Arun R, Kalsi-Ryan S, Massicotte EM, Kopjar B, Fehlings MG. Do quantitative magnetic resonance imaging parameters correlate with the clinical presentation and functional outcomes after surgery in cervical spondylotic myelopathy? A prospective multicenter study. Spine (Phila Pa 1976). 2014 Aug 15;39(18):1488-97. doi: 10.1097/BRS.0000000000000436. PMID: 24859570
Fehlings MG, Barry S, Kopjar B, Yoon ST, Arnold P, Massicotte EM, Vaccaro A, Brodke DS, Shaffrey C, Smith JS, Woodard E, Banco RJ, Chapman J, Janssen M, Bono C, Sasso R, Dekutoski M, Gokaslan ZL. In response. Spine (Phila Pa 1976). 2014 Jul 1;39(15):1265. PMID: 25184181
Fehlings MG, Barry S, Kopjar B, Yoon ST, Arnold P, Massicotte EM, Vaccaro A, Brodke DS, Shaffrey C, Smith JS, Woodard E, Banco RJ, Chapman J, Janssen M, Bono C, Sasso R, Dekutoski M, Gokaslan ZL. Response to, Letter to the Editor Regarding our Article Anterior vs Posterior Surgical Approaches to Treat Cervical Spondylotic Myelopathy: Outcomes of the Prospective Multicenter AOSpine North America CSM Study in 264 Patients. Spine (Phila Pa 1976). 2014 May 14. [Epub ahead of print] PMID: 24831505
Li ST, Liu Y, Zhou Q, Lue RF, Song L, Dong SW, Guo P, Kopjar B. A Novel Axial-Stress Bioreactor System Combined with a Substance Exchanger for Tissue Engineering of 3D Constructs. Tissue Eng Part C Methods. 2014 Mar;20(3):205-14. doi: 10.1089/ten.TEC.2013.0173. Epub 2013 Aug 15. PMID: 23822092
PI: Kopjar Dates: 4/1/2011 - 12/31/2016
The aim of this study is to evaluate efficacy and safety of riluzole in the treatment of patients with acute spinal cord injury (SCI).
Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)
Study of the efficacy of Riluzole in patients with cervical spondylotic myelopathy undergoing surgical treatment. A randomized, double-blind, placebo-controlled multi-center study